SHANGHAI, Dec. 7, 2010 /PRNewswire-Asia-FirstCall/ —
China-Biotics, Inc. (“China-Biotics” or “the Company”), (Nasdaq:
CHBT) the leading developer, manufacturer and distributor of
probiotics products in China, today announced that a delegation
from the Company’s research and development department presented at
the National Probiotics Research and Development, New Application
and Equipment seminar in Hangzhou, China on November 21st.
The seminar was organized and hosted by the National High-Tech
Industrialization Association. More than 180 research and
development professionals from global industry leaders and other
probiotics companies participated in the event.
The Company’s R&D specialists presented on bifidobacterium
infantis, focusing on the fermentation techniques, quality
assurance on product stability, and the application of
bifidobacterium infantis in health food products.
Mr. Jinan Song, Chairman and CEO of China-Biotics, commented,
“Research and development and the application of probiotics is
accelerating in China as consumers continue to grasp the beneficial
effects of probiotics. Meanwhile, the Chinese government is also
poised to implement stricter enforcement to reduce the use of
antibiotics use in animal feed. As a result, the probiotics
industry is experiencing linear growth with rising popularity among
consumers and favorable policy supports. Advancement in production
techniques and the gradual standardization of industry practices
have laid the foundation for more dairy and animal producers to
embrace probiotics.”
About China-BioticsChina-Biotics, Inc. (“China-Biotics” or
“the Company”), a leading manufacturer of biotechnology products
and supplements, engages in the research, development, marketing
and distribution of probiotics dietary supplements in China.
Through its wholly owned subsidiaries, Shanghai Shining
Biotechnology
‘/>”/>
